Caplin Point Laboratories Ltd
Caplin Point Lab | 524742
Stock Performance
Ratios
About Company
- Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990
- The Company is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market
- Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India
- It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections
- Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries
- In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well
- It manufactures products one among which is for injectables approved inter-alia by EU-GMP, INVIMA, Colombia, Anvisa, Brazil and US FDA
- Besides these, it has extended to regulated markets like USA (plans for Canada, Australia, China and Brazil)
- The company came out with a public issue in Nov
- '94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Frequently Asked Questions
What is Share Price of Caplin Point Laboratories Ltd?
The current share price of Caplin Point Laboratories Ltd (Caplin Point Lab) is ₹1943.20. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Caplin Point Laboratories Ltd?
The Price-to-Earnings (P/E) ratio of Caplin Point Laboratories Ltd is 1943.20. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd has a 52-week high of ₹2641.00 and a 52-week low of ₹1599.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd offers a dividend yield of 0.31%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Caplin Point Laboratories Ltd?
The Earnings Per Share (EPS) of Caplin Point Laboratories Ltd is ₹77.46. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd has a Return on Equity (ROE) of 21.97%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
